FDA Approves Epclusa for Chronic Hepatitis C

Share this content:
FDA Approves Epclusa for Chronic Hepatitis C
FDA Approves Epclusa for Chronic Hepatitis C

TUESDAY, June 28, 2016 (HealthDay News) -- The combination drug Epclusa has been approved by the U.S. Food and Drug Administration to treat the six major strains of chronic hepatitis C virus.

Epclusa combines sofosbuvir, FDA-approved in 2013, and the new drug velpatasvir. For patients with moderate-to-severe cirrhosis, Epclusa is approved to be used in combination with ribavirin. Epclusa also is approved for use in patients who haven't developed cirrhosis, the agency said Tuesday in a news release.

Epclusa was evaluated in clinical trials involving 1,558 patients. Up to 99 percent of participants given the drug had no virus detected in the blood 12 weeks after treatment, the FDA said. The most common side effects reported were headache and fatigue. The drug's label warns that Epclusa, when used with certain other drugs, including amiodarone, could lead to symptomatic bradycardia.

"This approval offers a management and treatment option for a wider scope of patients with chronic hepatitis C," Edward Cox, M.D., director of the Office of Antimicrobial Products in the FDA's Center for Drug Evaluation and Research, said in a statement.

Epclusa is produced and marketed by Gilead Sciences, based in Foster City, Calif.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

ASTRO: No Survival Benefit for Adding EBT to Brachytherapy

ASTRO: No Survival Benefit for Adding EBT to ...

Addition of external beam therapy doesn't improve five-year progression-free survival in prostate cancer

ASTRO: Fewer Side Effects With IMRT in Cervical, Endometrial CA

ASTRO: Fewer Side Effects With IMRT in Cervical, ...

Patients in conventional radiotherapy arm had more high-level adverse events than those in IMRT arm

Many Doctors Reluctant to Reveal Mental Health Issues

Many Doctors Reluctant to Reveal Mental Health Issues

Perceived stigma, fear of career repercussions hinder treatment, study suggests

is free, fast, and customized just for you!

Already a member?

Sign In Now »